David M. Jackson

CEO at Ceria Therapeutics

David M. Jackson, PhD is the CEO of Ceria Therapeutics and brings more than 25 years of experience specializing in the development and commercialization of innovative healthcare technologies addressing unmet market opportunities. He has led multiple product development efforts, fundraising campaigns, regulatory engagements and corporate transactions. Dr. Jackson earned a doctorate in the medical sciences from the Boston University School of Medicine; trained and experienced as a Patent Agent and Securities Analyst.

Links

Previous companies

QIAGEN logo

Timeline

  • CEO

    November, 2020 - present